Kennedy Capital Management, Inc. Opti Nose, Inc. Transaction History

Kennedy Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.75 - $8.38 $218,894 - $386,175	-46,083 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.4 - $10.94 $1.63 Million - $2.78 Million	-254,468 Reduced 84.67%	46,083 $326,000
Q1 2019 May 13, 2019	BUY	$6.1 - $10.3 $3,361 - $5,675	551 Added 0.18%	300,551 $3.1 Million
Q4 2018 Feb 12, 2019	BUY	$5.84 - $11.92 $1.75 Million - $3.58 Million	300,000 New	300,000 $1.86 Million

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.